首页> 外文期刊>Cancer genetics >A possible 5'-NRIP1/UHRF1-3' fusion gene detected by array CGH analysis in a Ph+ ALL patient
【24h】

A possible 5'-NRIP1/UHRF1-3' fusion gene detected by array CGH analysis in a Ph+ ALL patient

机译:通过阵列CGH分析在Ph + ALL患者中检测到可能的5'-NRIP1 / UHRF1-3'融合基因

获取原文
获取原文并翻译 | 示例
           

摘要

A translocation between chromosomes 19 and 21 [dic/t(19;21)(p13;v)] is very rare. To date, only three cases of this particular chromosomal abnormality have been reported. The translocations in these three cases were secondary changes in acute lymphoblastic leukemia (ALL) patients with the t(9;22) translocation. The gene(s) at the breakpoints of either chromosome 19p13 or 21q have not yet been identified. Here, we present a case study of a 21-year-old female with a diagnosis of precursor B cell ALL, with the t(9;22) translocation and secondary changes including a der(19)t(19;21) and an extra Philadelphia (Ph+) chromosome [der(22)t(9;22)]. Array comparative genomic hybridization (aCGH) analysis identified UHRF1 and NRIP1 as genes that were interrupted at the breakpoints of 19p13.3 and 21q21.1, and joined together as a possible fusion gene, 5'- NRIP1/UHRF1-3', on the derivative chromosome 19. To our knowledge, this is the first description of possible genes involved in the unbalanced translocation between chromosomes 19 and 21 in a patient with an ALL-positive for a t(9;22) translocation.
机译:染色体19和21之间的易位[dic / t(19; 21)(p13; v)]非常罕见。迄今为止,仅报道了三例这种特殊的染色体异常病例。这三例病例的易位是t(9; 22)易位的急性淋巴细胞白血病(ALL)患者的继发性改变。尚未鉴定出染色体19p13或21q的断点处的基因。在这里,我们提供了一个案例研究,其中一名21岁女性被诊断为前体B细胞ALL,具有t(9; 22)易位和包括der(19)t(19; 21)和费城(Ph +)额外染色体[der(22)t(9; 22)]。阵列比较基因组杂交(aCGH)分析确定UHRF1和NRIP1为在19p13.3和21q21.1的断点处中断的基因,并作为可能的融合基因5'- NRIP1 / UHRF1-3'连接到了衍生染色体19。据我们所知,这是对at(9; 22)易位ALL阳性患者中19号和21号染色体之间不平衡易位的可能基因的首次描述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号